Rapid Micro Biosystems Inc Class A (RPID)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$3.54

Buy

$4.50

arrow-down$-0.08 (-2.15%)

Prices updated at 12 Dec 2025, 21:10 EST
| Prices minimum 15 mins delay
|
Prices in USD

Sector
Healthcare
Industry
Medical Devices
Chairman
Dr. Kirk D. Malloy, PhD
CEO
Mr. Robert Spignesi
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
163
Head office
25 Hartwell Avenue
Lexington
United States
02421
mobile
+1 978 349-3200
letter
-

Key personnel

Salary
Dr. Dafni Bika
Director
-
Mr. Sean M. Wirtjes
Chief Financial Officer and Principal Accounting Officer
0.45m
Mr. Natale S. Ricciardi
Independent Director
0.05m
Dr. Kirk D. Malloy, PhD
Chairman of the Board
0.10m
Mr. Richard S. Kollender
Independent Director
0.06m
Ms. Melinda Litherland
Independent Director
0.06m
Mr. Jeffrey Schwartz, M.B.A.
Independent Director
0.05m
Mr. Robert Spignesi
Director, President and Chief Executive Officer
0.64m
Mr. John Wilson
Chief Operating Officer
0.45m
Ms. Inese Lowenstein
Independent Director
0.06m

Top 5 shareholders

No. of shares
Bain Capital Life Sciences Investors, LLC8,434,560
ABG-WTT Global Life Science Capital Partners GP Ltd1,848,296
Parkman Healthcare Partners LLC913,443
Vanguard Group Inc904,363
Schonfeld Strategic Advisors LLC646,579

Director dealings

Action
05 Dec 2024-
03 Dec 2024-
27 Nov 2024-
26 Nov 2024-
08 Aug 2024-
07 Aug 2024-
06 Aug 2024-
06 Aug 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
23 May 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.